UNSPSC 51183606: Insulin argine

This classification denotes a peptide hormone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 785P1QWQ1N, chemically known as insulin (human), 30ba-l-arginine-30bb-l-arginine-, but more generally known as insulin argine, which bears US NIH Compound Identifier 16132322. European Medicines Agency schedules Insulin argine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08194MIG. Most nations, for tariff and trade purposes, schedule insulin argine under HS 29371200 and SITC 54154.

SMILES: As of Q4 2014, INSULIN ARGINE remains US FDA's Preferred Term for this commodity.

UNSPSC 51183606 Insulin argine (Commodity) encompasses insulin arginine products supplied through multistate cooperative purchasing vehicles to state and local government healthcare facilities, including correctional institutions, mental health centers, and other public health programs. State and local governments procure this code as part of broader pharmaceutical supply agreements negotiated through cooperative alliances rather than individual jurisdictional solicitations, with purchases flowing through authorized drug wholesalers under framework contracts.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota, Oregon, and other member states. Vendors must maintain contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and demonstrate cGMP certification and Drug Supply Chain Security Act (DSCSA) compliance. Award weights price competitiveness at 75 percent, fixed pricing at 10 percent, and administrative compliance (EDI capability, fee format, 3 percent administrative fee acceptance) at 15 percent combined. The contract term runs two years for new responders with optional extensions, effective July 1, 2026, with awarded vendors required to maintain $5 million commercial general liability coverage, $2 million network security and privacy liability, and $2 million professional liability insurance.